Assessing and Reducing Risk of Violent Re-Injury Among Victims of Urban Violence

Violence Clinical Trial

— VOV-RCT  

Official title:

Assessing and Reducing Risk of Violent Re-Injury Among Victims of Urban Violence: A Randomized Clinical Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02257944
• Other study ID #: LSUHSC-8692
• Status: Not yet recruiting
• Phase: N/A
• First received: October 2, 2014
• Last updated: October 6, 2014
• Start date: October 2014
• Est. completion date: January 2016

Study information

• Verified date: October 2014
• Source: Conrad, Erich J., M.D.
• Contact: Erich J Conrad, MD
• Phone: 504-903-3417
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to develop a program to help people to lower their chances of being violently injured again.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: January 2016
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• age between 18-65 years

• intentionally injured in community violence.

• admitted to a Level 1 trauma center

• able to provide voluntary informed consent

Exclusion Criteria:

• under the age of 18 or over the age of 55.

• not fluent in the English language

• patients with suspected mental retardation or active psychosis as determined by brief clinical screen.

• patients currently in legal detention status

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Violence

Intervention

Behavioral:
• Motivational Interviewing
Brief hospital-based intervention, rooted in motivational interviewing

Other:
• Treatment as Usual
treatment as usual

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Conrad, Erich J., M.D.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Risk Factors for Violence	interview of risk factors	3 months	No